TY - JOUR T1 - <em>OXTR rs53576</em> variation with breast and nipple pain in breastfeeding women JF - medRxiv DO - 10.1101/2020.09.21.20199208 SP - 2020.09.21.20199208 AU - Ruth Lucas AU - Yiming Zhang AU - Stephen J. Walsh AU - Angela Starkweather AU - Erin Young Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/09/22/2020.09.21.20199208.abstract N2 - Purpose To evaluate associations among breast and nipple pain sensitivity and candidate pain sensitivity single-nucleotide polymorphisms [SNPs], (COMT rs6269, rs4633, rs4818, rs4680 and OXTR rs2254298, rs53576) in breastfeeding women.Design A secondary analysis of sixty women participating in a pilot randomized controlled trial of a pain self-management intervention.Methods All participants underwent standardized mechanical somatosensory testing for an assessment of pain sensitivity and provided baseline buccal swabs for genetic analysis. At 1, 2, and 6 weeks postpartum, women self-reported breast and nipple pain severity using a visual analogue scale.Results Women with the minor allele OXTR rs53576 reported 8.18-fold higher breast and nipple pain severity over time. For every 1-unit increase in mechanical detection threshold and windup ratio, women reported 16.51-fold and 4.82-fold higher breast and nipple pain severity respectively. Six women with the OXTR rs2254298 minor allele reported allodynia.Discussion The presence of OXTR alleles in women with enhanced pain sensitivity suggests a phenotype of genetic risk for ongoing breast and nipple with potential for pain-associated breastfeeding cessation. Somatosensory testing identified women who reported higher breast and nipple pain during the first weeks of breastfeeding.Clinical Implications Pain sensitivity testing can help to identify women at risk of intolerable and/or ongoing breastfeeding pain who may benefit from additional support to mitigate early breastfeeding cessation. Targeted interventions are needed to address breastfeeding pain, including management of infant latch, positioning, and infection as well as support for self-management of breastfeeding pain.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialClinical Trials.gov (NCT03392675)Clinical Protocols https://onlinelibrary.wiley.com/doi/abs/10.1002/nur.21938 Funding StatementFunded by NINR P20NR016605Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the University of Connecticut Institutional Review Board in 2017, and registered with Clinical Trials.gov (NCT03392675). All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDeidentified symptom data (including the data dictionary) will be provided to interested scientific investigators for the purpose of secondary research analysis by contacting the corresponding author and sending the investigators curriculum vitae and research questions. The study protocol and statistical analysis plan is available in our previous publication. https://cdrns.nih.gov/ ER -